Last updated: June 7, 2026

Back to directory

Aiberry medical AI product profile

AI-powered mental health assessment platform that uses a bot-administered conversation plus text, audio, and video signals to support supervised screening workflows.

Screenshot of the official Aiberry product page
Patient access, triage, and agents

Best fit

Organizations that need structured mental health screening or monitoring before a clinician, care manager, coach, or program team reviews risk scores and next steps.

Primary use case
AI-supported mental health screening, bot-administered interview intake, depression-risk scoring, symptom insights, transcript review, and longitudinal monitoring for clinician or program review
Audience
Behavioral health providers, recovery centers, employers, higher-education programs, correctional health teams, and mental health access leaders
Risk level
High
Pricing signal
Commercial platform pricing is not public; request current product, population, integration, validation, privacy, and implementation terms.
Official sources
5 official sources

Compare within workflow: Patient access, triage, and agents · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating Aiberry as safe for a local clinical, operational, or research workflow.

Regulatory / FDATreat as high-risk mental health screening or clinical decision-support software. Verify current medical-device status, intended use, jurisdiction, claims, and whether each configured score is wellness, screening, diagnostic support, or clinical assessment.
PrivacyReview video, audio, transcript, facial-behavior, text, score, and dashboard data flows; confirm consent, BAA/DPA coverage, retention, deletion, program-level reporting, support access, and model-improvement limits before deployment.
EvidenceCompare the cited validation study with the local population, language, setting, acuity, modality quality, baseline screening process, and follow-up workflow; monitor sensitivity, specificity, calibration, subgroup performance, and staff review burden.
WorkflowBest governed as supervised mental health screening and monitoring with explicit crisis escalation, clinician or care-team review, patient communication rules, and periodic safety review.

Where Aiberry fits

Aiberry describes an AI-powered mental health assessment platform using Botberry-administered conversations and text, audio, and video inputs to generate real-time scores, symptom insights, transcripts, and monitoring; its research pages describe a clinical validation study with UT Austin, Georgetown University, and the University of Arizona and report validation across ages 18 to 74 plus bias analyses by gender, age, ethnicity, and severity.

Not for: Emergency crisis support, autonomous diagnosis, replacing licensed mental health assessment, medication decisions, or broad surveillance without consent, governance, and human escalation.

What to verify before using Aiberry

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products